Saudi Arabia Self-Monitoring Blood Glucose Devices Market Size
| Study Period | 2017-2028 |
| Base Year For Estimation | 2022 |
| Forecast Data Period | 2024 - 2028 |
| Historical Data Period | 2018 - 2021 |
| CAGR | 6.42 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Saudi Arabia Self-Monitoring Blood Glucose Devices Market Analysis
The Saudi Arabia self-monitoring blood glucose devices market is expected to register a CAGR of 6.4% and reach a value of about USD 147 million over the forecast period.
Patients with diabetes infected with COVID-19 experienced elevated blood glucose, abnormal glucose variability, and diabetic complications. The prevalence of diabetes in people with COVID-19 caused a significant increase in the severity and mortality of COVID-19 in people with either type-1 or type-2 diabetes mellitus, especially in association with poor glycemic control. As diabetes already ranked higher among the major health issues in Saudi Arabia, there was an urgent need to provide an enhanced understanding of self-management, follow-up care, and glycemic management. While new-onset hyperglycemia and new-onset diabetes were increasingly recognized in the context of COVID-19 and associated with worse outcomes.
Blood glucose monitoring increases patients’ awareness of glucose values, which supports healthy lifestyle choices. Blood glucose monitoring values provide feedback and guidance on how to make health behavior changes when needed. Continued elevation in blood glucose levels in diabetes patients can contribute to progressive complications such as renal, nerve, and ocular damage. Appropriate and timely monitoring of blood glucose allows the successful management of out-of-range blood glucose levels, minimizing diabetic-related health complications.
Innovative technologies, such as digital health apps that display and summarize individual blood glucose measurements and additional relevant data such as insulin doses, meals, and physical activity, can further support self-management while decreasing disease burden and benefiting overall diabetes care. Integration of blood glucose monitoring with insulin calculators, automated insulin titration software, and remote coaching are further developments that provide patients with poorly controlled diabetes with the additional support needed to improve critical outcomes, thereby enhancing market prospects in the years to come.
Saudi Arabia Self-Monitoring Blood Glucose Devices Market Trends
Rising Diabetes Prevalence in Saudi Arabia
In Saudi Arabia, the diabetes population is expected to increase at a rate of about 7.3% over the forecast period.
More than one in ten people in Saudi Arabia were living with diabetes, and the prevalence of the disease was expected to almost double by 2045, according to the IDF 2021 report. The report further mentioned that 4.27 million people in Saudi Arabia, which has a population of about 34.8 million, have diabetes, while a further 1.86 million have the disease but are yet to be diagnosed. This figure is expected to increase to 5.6 million by 2030 and further increase to 7.5 million by 2045.
Obesity, especially central obesity, increased visceral fat due to physical inactivity, and the consumption of high-calorie, high-fat, and high-sugar foods are the major contributing factors to diabetes. Several initiatives, including taxing sugary drinks, focusing on fitness programs, and focusing on preventative care, are being taken by the government to stem this epidemic. Saudi Arabia is aiming to reduce the prevalence of diabetes by 10% over the next decade.
Monitoring blood glucose levels is an optimal way to confirm and appropriately treat hypoglycemia. It can provide feedback on the results of healthy behavior interventions and antihyperglycemic pharmacological treatments. It can increase one's adherence to treatment. It can also provide information to both the person with diabetes and their diabetes healthcare team to facilitate longer-term treatment modifications and shorter-term treatment decisions, such as insulin dosing for people with type 1 or type 2 diabetes.
The World Health Assembly Resolution 2022 recommended the integration of prevention and treatment of diabetes into primary health services, the development of pathways for a substantial increase in access to insulin, the promotion of convergence and harmonization of regulatory requirements for diabetes medicines and technologies, and improved diabetes monitoring and surveillance. Furthermore, it involves the WHO advising the Member States to ensure the uninterrupted treatment of people living with diabetes in humanitarian emergencies. This important milestone provides a global mandate for diabetes efforts for the next decade. Such initiatives are expected to create awareness among the public regarding the monitoring and control of diabetes, thereby enhancing market prospects in the years to come.
The Glucometer Devices Segment is expected to witness the highest CAGR over the forecast period
The glucometers segment is expected to register the highest CAGR of about 7.1% in the market over the forecast period owing to the increasing adoption of glucometers in home care settings, the growing preference for home-based self-monitoring, and recent product launches of advanced glucometers.
Glucose monitoring gives people living with diabetes a more complete picture of their blood sugar levels, which can influence short- and long-term treatment decisions and improve health outcomes. It allows them and their healthcare providers to assess their glycemic status and adverse effects and to determine the effectiveness of glucose-lowering therapies. Glucose monitoring has the potential to improve blood sugar management and quality of life for people living with diabetes, resulting in physical, social, emotional, and functional benefits.
Capillary blood glucose monitoring, or self-monitoring of blood glucose, is one way for people living with diabetes to measure and assess their glucose levels. It uses a drop of blood from a finger prick to get a blood glucose reading using a blood glucose meter or glucometer. Those with diabetes are advised to work with their care team to determine the frequency and pattern of testing.
In July 2022, the Saudi government announced that Saudi Arabia saw growing demand for quality healthcare services, spurred by changes including an increasing and aging population and a growing prevalence of diabetes. The government and private sector are both involved in working on healthcare entities, certifications, and regulations. The government is taking steps to have 100 percent of Saudi citizens covered by insurance and is working towards ensuring affordability, access, and quality digital healthcare and primary care with cost-effectiveness.
The aforementioned factors are likely to drive segment growth during the forecast period.
Saudi Arabia Self-Monitoring Blood Glucose Devices Industry Overview
The Saudi Arabia self-monitoring blood glucose devices market is moderately fragmented, with few significant and other generic players. Manufacturers like Abbott, LifeScan, F. Hoffmann-La Roche AG, Ascensia, etc. occupy a major share.
Saudi Arabia Self-Monitoring Blood Glucose Devices Market Leaders
Roche Diabetes Care
Abbott Diabetes Care
Ascensia Diabetes Care
LifeScan
Arkray
*Disclaimer: Major Players sorted in no particular order
Saudi Arabia Self-Monitoring Blood Glucose Devices Market News
- January 2023: LifeScan announced that the peer-reviewed Journal of Diabetes Science and Technology published Improved Glycemic Control Using a Bluetooth-Connected Blood Glucose Meter and a Mobile Diabetes App: Real-World Evidence From Over 144,000 People With Diabetes, detailing results from a retrospective analysis of real-world data from over 144,000 people with diabetes—one of the largest combined blood glucose meter and mobile diabetes app datasets ever published.
- January 2022: Roche launched its new point-of-care blood glucose monitor designed for hospital professionals, with a companion device shaped like a touchscreen smartphone that will run its own apps. The hand-held Cobas Pulse included an automated glucose test strip reader as well as a camera and touchscreen for logging other diagnostic results. It was designed to be used with patients of all ages, including neonates and people in intensive care.
Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.3 Market Restraints
4.4 Porter's Five Forces Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Consumers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products and Services
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 Component
5.1.1 Glucometer Devices
5.1.2 Test Strips
5.1.3 Lancets
6. MARKET INDICATORS
6.1 Type-1 Diabetes population
6.2 Type-2 Diabetes population
7. COMPETITIVE LANDSCAPE
7.1 COMPANY PROFILES
7.1.1 Abbott Diabetes Care
7.1.2 Roche Diabetes Care
7.1.3 LifeScan
7.1.4 Nipro
7.1.5 Ascensia Diabetes Care
7.1.6 VitalAire
7.1.7 Menarini
7.1.8 Rossmax International Ltd.
7.1.9 Arkray Inc.
- *List Not Exhaustive
7.2 COMPANY SHARE ANALYSIS
7.2.1 Abbott Diabetes Care
7.2.2 Roche Diabetes Care
7.2.3 LifeScan
7.2.4 Other Company Share Analyses
8. MARKET OPPORTUNITIES AND FUTURE TRENDS
Saudi Arabia Self-Monitoring Blood Glucose Devices Industry Segmentation
Self-monitoring of blood glucose is an approach used by diabetic patients to measure their blood sugar level themselves using a glucometer, test strips, and lancets. Based on the readings, patients can adjust or check the effect of their treatment. The Saudi Arabia self-monitoring blood glucose device market is segmented by components (glucometer devices, test strips, and lancets). The report offers the value (in USD million) and volume (in units million) for the above segments.
| Component | |
| Glucometer Devices | |
| Test Strips | |
| Lancets |
Frequently Asked Questions
What is the current Saudi Arabia Self-Monitoring Blood Glucose Devices Market size?
The Saudi Arabia Self-Monitoring Blood Glucose Devices Market is projected to register a CAGR of 6.42% during the forecast period (2023-2028).
Who are the key players in Saudi Arabia Self-Monitoring Blood Glucose Devices Market?
Roche Diabetes Care, Abbott Diabetes Care, Ascensia Diabetes Care, LifeScan and Arkray are the major companies operating in the Saudi Arabia Self-Monitoring Blood Glucose Devices Market.
Saudi Arabia Self-Monitoring Blood Glucose Devices Industry Report
Statistics for the 2023 Saudi Arabia Self-Monitoring Blood Glucose Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Saudi Arabia Self-Monitoring Blood Glucose Devices analysis includes a market forecast outlook to for 2023 to 2028 and historical overview. Get a sample of this industry analysis as a free report PDF download.
